MedTrace Logo

Confirmatory Study: Assessing the Efficacy and Safety of the AcusMu Microneedle Patch in Treating Periorbital Wrinkles

NCT06158867 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-12-04

Study results available
· View outcomes & findings →

Summary

The core objective of this study is to validate the safe and efficacious application of the AcusMu microneedle patch (FMD WK) to enhance the appearance of periorbital wrinkle

Conditions

  • Wrinkle

Interventions

DEVICE

FMD WK

micro-needle patches containing active anti-wrinkle ingredients

Sponsors & Collaborators

  • Taipei Medical University Hospital

    collaborator OTHER

  • AcusMu Medtech Co., Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-24
Primary Completion
2024-01-26
Completion
2024-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06158867 on ClinicalTrials.gov